19.
Item No.

20.
Schedule Of Supplies/Services

21.
Quantity

22.
Unit

23.
Unit Price

24.
Amount32a. Quantity In Column 21 Has Been
Received

Inspected

Accepted, And Conforms To The Contract, Except As Noted: _________________________________________________

32b. Signature Of Authorized Government Representative

32c. Date

32d. Printed Name and Title of Authorized Government Representative

32e. Mailing Address of Authorized Government Representative

32f. Telephone Number of Authorized Government Representative
32g. E-Mail of Authorized Government Representative

33. Ship Number
Partial34. Voucher Number

35. Amount Verified
Correct For

39. S/R Voucher Number

40. Paid By

Final

38. S/R Account No.

36. Payment
Complete

41a. I Certify This Account Is Correct And Proper For Payment
41b. Signature And Title Of Certifying Officer
41c. Date

37. Check Number
PartialFinal

42a. Received By (Print)
42b. Received At (Location)
42c. Date Rec’d (YY/MM/DD)

42d. Total Containers
Standard Form 1449 (Rev. 2/2012) Back

Reference No. of Document Being Continued

CONTINUATION SHEET

Page

2

of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
SUPPLEMENTAL INFORMATION

Buyer Name: (b) (6)Buyer Office Symbol/Telephone Number: CCNJ-IC/(b) (6)Type of Contract 1: Firm Fixed Price
Kind of Contract: Supply Contracts and Priced Orders
Type of Business: Large Business Performing in U.S.
Surveillance Criticality Designator: A*** End of Narrative A0000 ***Executive Summary
Background:
The Department of Health and Human Services (DHHS) continuously monitors emerging infectious disease risk and prepares to respond to thethreat of novel emerging infectious disease outbreaks in the United States. DHHS is responding to an outbreak of respiratory diseasecaused by a novel coronavirus that was first detected in China and which has now spread to worldwide, including in the United States.
The virus has been named SARS-CoV-2 and the disease it causes has been named coronavirus disease 2019 (abbreviated COVID-19).
On January 30, 2020, the International Health Regulations Emergency Committee of the World Health Organization (WHO) declared theoutbreak a public health emergency of international concern (PHEIC). On January 31, Health and Human Services Secretary Alex M. Azar II
declared a public health emergency (PHE) for the United States to aid the nations healthcare community in responding to COVID-19. On
March 11, WHO publicly characterized COVID-19 as a pandemic. On March 13, the President of the United States declared the COVID-19
outbreak a national emergency. Vaccination is often the most effective measure for the control of infectious diseases. In July 2020, the
DOD awarded an Other Transaction Agreement under the authority 10 USC 2371b to Pfizer to scale up manufacture of their BNT162b2 vaccine
candidate. The candidate entered Phase 3 clinical trials and scale up of their manufacturing processes. On November 9, 2020, Pfizer
announced that BNT162b2 was >90% effective based on interim analysis of partial data from their Phase 3 clinical trial. On November 18,
2020, Pfizer reported 95% effectiveness based on analysis of a larger dataset that included 170 confirmed cases among the Phase 3
volunteers (162 in the placebo group and 8 in the vaccinated group). Based on the strength of this data, Pfizer formally requested
Emergency Use Authorization (EUA) from the US Food and Drug Administration.
1. This action has a total Firm Fixed Price value of $10,016,418,500 inclusive of all options. At this time, CLINs 0001, 0002, and 0003
are funded in the amount of $2,011,282,500.
2. The Representations and Certifications made by Pfizer in the System for Award Management (SAM) are hereby incorporated into thiscontract by reference.
3. The Pfizer Small Business Subcontracting Plan, dated 01 March 2020 is hereby incorporated into the contract (see Attachment 0002).

*** END OF NARRATIVE A0001 ***Page

Reference No. of Document Being Continued

CONTINUATION SHEET

3 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO

SUPPLIES/SERVICESQUANTITY

UNIT

UNIT PRICEAMOUNT

50000000

EA$______(b) (4)$____(b) (4)50000000

EA$______(b) (4)$____(b) (4)

SUPPLIES OR SERVICES AND PRICES/COSTS

0001

COVID Vaccines
NSN: 9999-99-999-9999

0001AA

COVID-19 VACCINE (BNT162B2)___________________________COMMODITY NAME: COVID Vaccines
CLIN CONTRACT TYPE:
Firm Fixed Price
PRON: CB1RD45726
PRON AMD: 01
PSC: 6505

ACRN: AA

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR
001 W56XNH10356002 75A501
J
DEL REL CD________________________QUANTITY___________DEL DATE
001
50,000,000
30-JUN-2021

_____
TP
CD
3

FOB POINT: Destination
SHIP TO:(75A501)

0001AB

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

COVID-19 VACCINE (BNT162B2)___________________________COMMODITY NAME: Vaccines
CLIN CONTRACT TYPE:
Firm Fixed Price
PRON: CB1RD26995
PRON AMD: 01
PSC: 6505

ACRN: ABPackaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination

CONTINUATION SHEET

Page

Reference No. of Document Being Continued

4 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO

SUPPLIES/SERVICESQUANTITY_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR
001 W56XNH10353001 75A501
J
DEL REL CD________________________QUANTITY___________DEL DATE001
20,000,000
30-JUN-2021002

30,000,000

UNIT

UNIT PRICEAMOUNT

_____
TP
CD
3

31-JUL-2021

FOB POINT: Destination
SHIP TO:(75A501)

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

0002

COVID VACCINE DILUENTNSN: 9999-99-999-9999

0002AADILUENT______________________(b) (4)

COMMODITY NAME: COVID VACCINE DILUENT
CLIN CONTRACT TYPE:
Firm Fixed Price
PRON: CB1RD60238
PRON AMD: 01
ACRN: AC
PSC: 6505

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR
001 W56XNH10357003 75A501
J
DEL REL CD________________________QUANTITY___________DEL DATE
001
30-JUN-2021(b) (4)002(b) (4)31-JUL-2021

FOB POINT: Destination
SHIP TO:(75A501)

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

_____
TP
CD
3

EA

$_______(b) (4)$_____(b) (4)Page

Reference No. of Document Being Continued

CONTINUATION SHEET

5 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO

0002AB

SUPPLIES/SERVICESQUANTITYDILUENT_______UNIT(b) (4)EA

1EA

UNIT PRICE$_______(b) (4)AMOUNT$_____(b) (4)

COMMODITY NAME: COVID VACCINE DILUENT
CLIN CONTRACT TYPE:
Firm Fixed Price
PRON: CB1RD59428
PRON AMD: 01
ACRN: AD
PSC: 6505

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR
001 W56XNH10357002 75A501
J
DEL REL CD________________________QUANTITY___________DEL DATE
001
31-JUL-2021(b) (4)

_____
TP
CD
3

FOB POINT: Destination
SHIP TO:(75A501)

0003

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

OCONUS SHIPPING_______________SERVICE REQUESTED: COVID Shipping
CLIN CONTRACT TYPE:
Time and Materials

PRON: CB1RD47628

PRON AMD: 01_________________________
Inspection
and Acceptance
INSPECTION: Destination

ACRN: AEACCEPTANCE: Destination_________________________
Deliveries
or Performance
Period of Performance(b) (4)DLVR SCH________REL CD
001______________QUANTITY
1$(b) (4)

PERF COMPL__________
DATE
17-MAR-2022$_____(b) (4)Page

Reference No. of Document Being Continued

CONTINUATION SHEET

6 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO

0004

SUPPLIES/SERVICES

COVID-19 VACCINE (BNT162B2) OPTION 1____________________________________QUANTITY

UNIT

UNIT PRICEAMOUNT

25000000

EA$______(b) (4)$____(b) (4)(b) (4)

EA$_______(b) (4)$_____(b) (4)

COMMODITY NAME: BNT162B2 OPTION 1
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001
25,000,000(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

0005

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

DILUENT OPTION 1________________COMMODITY NAME: DILUENT OPTION 1
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD______
001

MARK FOR________

TP CD
_____

Page

Reference No. of Document Being Continued

CONTINUATION SHEET

7 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO

SUPPLIES/SERVICES__________DEL
REL CD
001______________QUANTITYQUANTITY

UNIT

UNIT PRICEAMOUNT

25000000

EA$______(b) (4)$____(b) (4)(b) (4)

EA$_______(b) (4)$_____(b) (4)DAYS AFTER AWARD________________(b) (4)(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

0006

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

COVID-19 VACCINE (BNT162B2) OPTION 2____________________________________COMMODITY NAME: BNT162B2 OPTION 2
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001
25,000,000(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

0007

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

DILUENT OPTION 2________________COMMODITY NAME: DILUENT OPTION 2
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

CONTINUATION SHEET

Page

Reference No. of Document Being Continued

8 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO

SUPPLIES/SERVICESQUANTITY

UNIT

25000000EAUNIT PRICEAMOUNT

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001(b) (4)(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

0008

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

COVID-19 VACCINE (BNT162B2) OPTION 3____________________________________COMMODITY NAME: BNT162B2 OPTION 3
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001
25,000,000(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201$______(b) (4)$____(b) (4)Page

Reference No. of Document Being Continued

CONTINUATION SHEET

9 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO
0009

SUPPLIES/SERVICESDILUENT OPTIION 3_________________QUANTITY

UNIT

UNIT PRICEAMOUNT(b) (4)

EA$_______(b) (4)$_____(b) (4)25000000

EA$______(b) (4)$____(b) (4)

COMMODITY NAME: DILUENT OPTIION 3
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001(b) (4)(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)0010

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

COVID-19 VACCINE (BNT162B) OPTION 4___________________________________COMMODITY NAME: BNT162B OPTION 4
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001
25,000,000(b) (4)

Page

Reference No. of Document Being Continued

CONTINUATION SHEET

10 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO

SUPPLIES/SERVICESQUANTITY

UNIT

UNIT PRICEAMOUNTFOB POINT: Destination
SHIP TO:(75A501)

0011

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

DILUENT OPTION 4________________(b) (4)

EA$_______(b) (4)$_____(b) (4)25000000

EA$______(b) (4)$____(b) (4)

COMMODITY NAME: DILUENT OPTION 4
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001(b) (4)(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

0012

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

COVID-19 VACCINE (BNT162B2) OPTION 5____________________________________COMMODITY NAME: BNT162B2 OPTION 5
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking_____________________

Inspection and Acceptance_________________________

Page

Reference No. of Document Being Continued

CONTINUATION SHEET

11 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO

SUPPLIES/SERVICESINSPECTION: Destination

QUANTITY

UNIT

UNIT PRICEAMOUNT

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001
25,000,000(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

0013

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

DILUENT OPTION 5________________(b) (4)

EA$_______(b) (4)$_____(b) (4)25000000

EA$______(b) (4)$____(b) (4)

COMMODITY NAME: DILUENT OPTION 5
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001(b) (4)(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

0014

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

COVID-19 VACCINE (BNT162B2) OPTION 6____________________________________COMMODITY NAME: BNT162B2 OPTION 6

Page

Reference No. of Document Being Continued

CONTINUATION SHEET

12 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO

SUPPLIES/SERVICESQUANTITY

UNIT

UNIT PRICEAMOUNT

PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001
25,000,000(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

0015

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

DILUENT OPTION 6________________(b) (4)

COMMODITY NAME: DILUENT OPTION 6
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001(b) (4)(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

OFFICE OF ACQMGMT POLICY

EA$_______(b) (4)$_____(b) (4)Page

Reference No. of Document Being Continued

CONTINUATION SHEET

13 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO

SUPPLIES/SERVICESQUANTITY

UNIT

UNIT PRICEAMOUNT

25000000

EA$______(b) (4)$____(b) (4)(b) (4)

EA$_______(b) (4)$_____(b) (4)HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

0016

COVID-19 VACCINE (BNT162B2) OPTION 7____________________________________COMMODITY NAME: BNT162B2 OPTION 7
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001
25,000,000(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

0017

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

DILUENT OPTION 7________________COMMODITY NAME: DILUENT OPTION 7
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

Deliveries or Performance_________________________

ACCEPTANCE: Destination

Page

Reference No. of Document Being Continued

CONTINUATION SHEET

14 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO

SUPPLIES/SERVICESQUANTITY

UNIT

UNIT PRICEAMOUNT

25000000

EA$______(b) (4)$____(b) (4)(b) (4)

EA$_______(b) (4)$_____(b) (4)

DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001(b) (4)(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

0018

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

COVID-19 (BNT162B2) OPTION 8____________________________COMMODITY NAME: (BNT162B2) OPTION 8
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001
25,000,000(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

0019

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

DILUENT OPTION 8________________COMMODITY NAME: DILUENT OPTION 8
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

CONTINUATION SHEET

Page

Reference No. of Document Being Continued

15 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO

SUPPLIES/SERVICESQUANTITY

UNIT

25000000EAUNIT PRICEAMOUNT

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001(b) (4)(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)0020

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

COVID-19 VACCINE (BNT162B2) OPTION 9____________________________________COMMODITY NAME: BNT162B2 OPTION 9
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________(b) (4)001
25,000,000

FOB POINT: Destination
SHIP TO:(75A501)

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201$______(b) (4)$____(b) (4)Page

Reference No. of Document Being Continued

CONTINUATION SHEET

16 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO

0021

SUPPLIES/SERVICESDILUENT OPTION 9________________QUANTITY

UNIT

UNIT PRICEAMOUNT(b) (4)

EA$_______(b) (4)$_____(b) (4)25000000

EA$______(b) (4)$____(b) (4)

COMMODITY NAME: DILUENT OPTION 9
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________(b) (4)001(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

0022

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

COVID-19 VACCINE (BNT162B2) OPTION 10_____________________________________COMMODITY NAME: BNT162B2 OPTION 10
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________

CONTINUATION SHEET

Page

Reference No. of Document Being Continued

17 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO

SUPPLIES/SERVICES
001

25,000,000

QUANTITY

UNIT

UNIT PRICEAMOUNT(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

0023

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

DILUENT OPTION 10_________________(b) (4)

EA$_______(b) (4)$_____(b) (4)25000000

LO$______(b) (4)$____(b) (4)

COMMODITY NAME: DILUENT OPTION 10
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001(b) (4)(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

0024

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

COVID-19 VACCINE (BNT162B2) OPTION 11_____________________________________COMMODITY NAME: BNT162B2 OPTION 11
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking_____________________

CONTINUATION SHEET

Page

Reference No. of Document Being Continued

18 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO

SUPPLIES/SERVICES_________________________
Inspection
and Acceptance
INSPECTION: Destination

QUANTITY

UNIT

UNIT PRICEAMOUNT

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________(b) (4)001
25,000,000

FOB POINT: Destination
SHIP TO:(75A501)

0025

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

DILUENT OPTION 11_________________(b) (4)

EA$_______(b) (4)$_____(b) (4)25000000

EA$______(b) (4)$____(b) (4)

COMMODITY NAME: DILUENT OPTION 11
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001(b) (4)(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

0026

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

COVID-19 VACCINE (BNT162B2) OPTION 12_____________________________________

CONTINUATION SHEET

Page

Reference No. of Document Being Continued

19 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO

SUPPLIES/SERVICESQUANTITY

UNIT

UNIT PRICEAMOUNT

COMMODITY NAME: BNT162B2 OPTION 12
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001
25,000,000(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)0027

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

DILUENT OPTION 12_________________(b) (4)

COMMODITY NAME: DILUENT OPTION 12
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001(b) (4)(b) (4)

FOB POINT: Destination

EA$_______(b) (4)$_____(b) (4)CONTINUATION SHEET

Page

Reference No. of Document Being Continued

20 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO

SUPPLIES/SERVICES
SHIP TO:(75A501)0028

QUANTITY

UNIT

UNIT PRICEAMOUNT

25000000

EA$______(b) (4)$____(b) (4)(b) (4)

EA$_______(b) (4)$_____(b) (4)OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

COVID-19 VACCINE (BNT162B2) OPTION 13_____________________________________COMMODITY NAME: BNT162B2 OPTION 13
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001
25,000,000(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

0029

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

DILUENT OPTION 13_________________COMMODITY NAME: DILUENT OPTION 13
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination

CONTINUATION SHEET

Page

Reference No. of Document Being Continued

21 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO

SUPPLIES/SERVICESQUANTITY

UNIT

UNIT PRICEAMOUNT

25000000

EA$______(b) (4)$____(b) (4)(b) (4)

EA$_______(b) (4)$_____(b) (4)_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________(b) (4)001(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)0030

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

COVID-19 VACCINE (BNT162B2) OPTION 14_____________________________________COMMODITY NAME: BNT162B2 OPTION 14
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001
25,000,000(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

0031

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

DILUENT OPTION 14_________________COMMODITY NAME: DILUENT OPTION 14
PSC: 6505

CONTINUATION SHEET

Page

Reference No. of Document Being Continued

22 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO

SUPPLIES/SERVICESQUANTITY

UNIT

25000000EAUNIT PRICEAMOUNT

CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001(b) (4)(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

0032

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

COVID-19 VACCINE (BNT162B2) OPTION 15_____________________________________COMMODITY NAME: BNT162B2 OPTION 15
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001
25,000,000(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200$______(b) (4)$____(b) (4)CONTINUATION SHEET

Page

Reference No. of Document Being Continued

23 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO

SUPPLIES/SERVICESQUANTITY

UNIT

UNIT PRICEAMOUNTINDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

0033

DILUENT OPTION 15_________________(b) (4)

EA$_______(b) (4)$_____(b) (4)25000000

EA$______(b) (4)$____(b) (4)

COMMODITY NAME: DILUENT OPTION 15
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001(b) (4)(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

0034

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

COVID-19 VACCINE (BNT162B2) OPTION 16_____________________________________COMMODITY NAME: BNT162B2 OPTION 16
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination_________________________
Deliveries
or Performance
DOC
SUPPL

ACCEPTANCE: Destination

Page

Reference No. of Document Being Continued

CONTINUATION SHEET

24 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO

SUPPLIES/SERVICESQUANTITY

UNIT

UNIT PRICEAMOUNT______RELCD
MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001
25,000,000(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

0035

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

DILUENT OPTION 16_________________(b) (4)

COMMODITY NAME: DILUENT OPTION 16
PSC: 6505
CLIN CONTRACT TYPE:
Firm Fixed Price

Packaging and Marking______________________________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DOC
SUPPL
REL CD______MILSTRIP________ADDR______SIG CD ______________MARK FOR _____
TP CD
001
DEL REL CD________________________QUANTITYDAYS AFTER AWARD________________
001(b) (4)(b) (4)

FOB POINT: Destination
SHIP TO:(75A501)

0036

OFFICE OF ACQ MGMT POLICY
HUBERT HUMPHREY BLDG 200
INDEPENDENCE AVENUE SW ROOM 336E
WASHINGTON,DC,20201

CONTRACT DATA REQIREMENTS LIST______________________________The ELIN below is associated with the Data Item
numbers in the Contract Data Requirements List (CDRL,
DD 1423), in Section J. Reference individual CDRLs
for applicable instructions and delivery dates.
(End of narrative A001)

EA$_______(b) (4)$_____(b) (4)Reference No. of Document Being Continued

CONTINUATION SHEETPage

25 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
ITEM NO

A001

SUPPLIES/SERVICES

DD1423 CDRLS A001 THROUGH A003______________________________SERVICE REQUESTED: DATA ITEMS
CLIN CONTRACT TYPE:
Firm Fixed Price_________________________
Inspection
and Acceptance
INSPECTION: Destination

ACCEPTANCE: Destination_________________________
Deliveries
or Performance
DLVR SCH________REL CD______________QUANTITY
001
1

PERF COMPL__________DATESEE DD FORM 1423

QUANTITY

UNIT

1

LO

UNIT PRICEAMOUNT$__________________** NSP **Reference No. of Document Being Continued

CONTINUATION SHEET

Page 26 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
DESCRIPTION/SPECIFICATIONS/WORK STATEMENTSTATEMENT OF WORK
Production of COVID-19 BNT162b2 Vaccine in Support of National Emergency Response to Coronavirus 2019 (COVID-19)
C.1 Scope: The Department of Defense (DOD) and Department of Health and Human Services (DHHS) in support of national emergency responseto the Coronavirus Disease 2019 (COVID-19) requires the production of Pfizer vaccine BNT162b2 on a commercial item basis, up to 500
million doses to inoculate members of the DOD and the general population from the SARS CoV-2 Virus.
C.1.1 Background: The DHHS continuously monitors emerging infectious disease risk and prepares to respond to the threat of novel
emerging infectious disease outbreaks in the United States. DHHS is responding to an outbreak of respiratory disease caused by a novel
coronavirus that was first detected in China and which has now spread worldwide, including in the United States. The virus has been
named SARS-CoV-2 and the disease it causes has been named coronavirus disease 2019 (abbreviated COVID-19).
On January 30, 2020, the International Health Regulations Emergency Committee of the World Health Organization (WHO) declared theoutbreak a public health emergency of international concern (PHEIC). On January 31, the Health and Human Services Secretary declared apublic health emergency (PHE) for the United States to aid the nations healthcare community in responding to COVID-19. On March 11, WHOpublicly characterized COVID-19 as a pandemic. On March 13, the President of the United States declared the COVID-19 outbreak a national
emergency. Vaccination is often the most effective measure for the control of infectious diseases.
In July 2020, the DOD awarded an Other Transaction Agreement under the authority 10 USC 2371b to Pfizer to scale up manufacture of their
BNT162b2 vaccine candidate. The candidate entered Phase 3 clinical trials and scale up of their manufacturing processes. On November
9, 2020, Pfizer announced that BNT162b2 was >90% effective based on interim analysis of partial data from their Phase 3 clinical trial.
On November 18, 2020, Pfizer reported 95% effectiveness based on analysis of a larger dataset that included 170 confirmed cases among
the Phase 3 volunteers (162 in the placebo group and 8 in the vaccinated group). Based on the strength of this data, Pfizer formallyrequested Emergency Use Authorization (EUA) from the US Food and Drug Administration.
As part of DHHS preparedness and response activities, DHHS seeks to purchase 500M doses of the EUA authorized (or Biologics License
Application (BLA) approved) BNT162b2 vaccine, enough to vaccinate the entire American population.
C.2 Objectives: The contractor shall produce up to 500M doses of vaccine under the following schedule:
Base Quantity 100M doses. Pfizer shall make best effort to deliver the 100M doses by 30 June 2021, but shall be required to deliver noless than 70M doses by 30 June 2021, (b) (4)If Pfizer is unable to deliver 100M doses by 30 June 2021, Pfizer will deliver the balance of doses no later than 31 July 2021.
Options 1 through 16

25M doses each.

(b) (4)

C.3 Requirements:
C.3.1 Vaccine: The contractor shall deliver to Government designated sites, EUA authorized (or BLA approved) drug product intemperature controlled (BNT162b2) Suspension for Intramuscular injection Multiple Dose Vials. The Contractor shall be liable for riskof loss due to breakage, temperature excursion, or other, until Government formally accepts the product on site (FOB Destination). The
contractor will coordinate ordering through centralized distribution via the established BARDA Data Infrastructure (BDI) system.
C.3.2 Diluent: The contractor shall ensure delivery, either concurrent with or in advance of the vaccine, of FDA approved diluent insufficient quantities to dilute the number of vaccine doses to be delivered.
The contractor will coordinate ordering through centralized distribution via the established BDI system. For clarity, the Government
has retained McKesson to source all of the components needed to support preparation of kits for the mixing and administration of thevaccine; however, Pfizer will: (i) source the diluent for such kits and pay for the delivery of such diluent to McKesson; (ii) pay
McKesson for the labor required of McKesson to assemble and pack the diluent into the kits; and (iii) pay McKesson to ship the kits tothe ship-to locations specified by the Government.
The Government acknowledges that other than the diluent provided by Pfizer, any and all other items included in the kits are not being
supplied or otherwise provided by or on behalf of Pfizer and are neither the property nor the responsibility of Pfizer. Other thandiluent, Pfizer will not provide any other ancillary items under this contract, including, but not limited to, syringes, needles,
alcohol swabs, and/or personal protective equipment. Further, the Government acknowledges that Pfizers responsibility for provision ofdiluent will cease upon acceptance of delivery by the ship-to location specified by the Government.
C.3.3 RESERVEDCONTINUATION SHEET

Reference No. of Document Being Continued

Page 27 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
C.4 Reporting: The contractor shall provide the following reports:
C.4.1 Shipping Documentation Finished Drug Product. The contractor shall provide all documentation required for Government review ofvaccine lot release prior to shipment. Specifically, (b) (4)C.4.2 FDA Interactions and Inspections Documentation. Pfizer shall provide the Government (b) (4)of receipt any FDA Form 483,
Establishment Inspection Report (EIR), regulatory authorization or approval-related letter and/or warning or untitled letter (b) (4)including status ofEmergency Use Authorization and/or Biologics License Application approval.
C.4.3 Manufacturing Reports and Dose Tracking Projections/Actuals aligned with the BARDA Data Infrastructure. Pfizer shall provide Dose
Tracker Projections (Weekly) (b) (4)- once performance under one or more supply CLINs has begun)
utilizing the COVID-19 Dose Tracking US HHS, ASPR/BARDA Template version 2.2 (9/21/2020) format. Any changes to the format must be
mutually agreed by the parties.
C.5. INTENTIONALLY LEFT BLANK
C.6 Inspection/Acceptance:
For avoidance of doubt, the Government and Pfizer acknowledge that the Government cannot direct Pfizer to deliver and Pfizer cannot
deliver to ship-to locations in the absence of an active EUA or approved BLA.
(b) (4)

C.7 Packaging and Marking: The contractor shall label product according to FDA guidance/instructions.
with the contractor's standard commercial practice.
C.8 Government Technical Point of Contact(b) (6)
HHS BARDA

Packaging shall be in accordance

CONTINUATION SHEET

Reference No. of Document Being Continued
W15QKN-21-C-0012

PIIN/SIIN

Name of Offeror or Contractor: PFIZER INC.
(b) (6)(b) (6)@hhs.gov*** END OF NARRATIVE C0001 ***MOD/AMD

Page 28 of 51

CONTINUATION SHEET

Reference No. of Document Being Continued

Page 29 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
INSPECTION AND ACCEPTANCE

1
2

Regulatory Cite_______________
52.246-2
52.246-16______________________________________________________________________Title
INSPECTION OF SUPPLIES--FIXED-PRICERESPONSIBILITY FOR SUPPLIES____________Date
AUG/1996
APR/1984

CONTINUATION SHEET

Reference No. of Document Being Continued

Page 30 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
DELIVERIES OR PERFORMANCE

1

Regulatory Cite_______________
52.247-34______________________________________________________________________
Title
F.O.B. DESTINATION____________
Date
NOV/1991

Shipping
The cost of shipping product within the United States (defined for purposes of this clause to include CONUS, Puerto Rico, Alaska and
Hawaii) is included within the contract price for vaccine and diluent. For shipments to U.S. Territories other than Puerto Rico,(inclusive of American Samoa, Guam, Marshall Islands, Northern Mariana Islands, U.S. Virgin Islands), Pfizer will cover shipment costs
for one weekly shipment each of diluent and vaccine to each Territory on a standard commercial carrier. For Palau and Micronesia, forwhich commercial delivery is less frequent or only available on an ad hoc basis, Pfizer will cover commercial delivery as available not
to exceed once per week.
Import duties associated with all shipments outside of the United States (b) (4).
All product required for U.S. installations overseas will be shipped to and accepted by the Government at Department of Defense
Activity Address Codes (DoDAACs) within the continental United States, with any exceptions requiring mutual agreement by the Government
and Pfizer. Shipments to locations not included here will be handled on a case-by-case basis.
______________________________The Government acknowledges that Pfizer is deemed to have met the deliverables identified in this Section Deliveries or Performance of
this contract in performance of prototype agreement MCDC2011-003. Pfizer commits to maintain these deliverables during performance of
this contract. Should Pfizer implement any material changes relevant to these deliverables during contract performance, it shall provide
notice to the Government within 30 calendar days.
I. Supply Chain Resiliency Plan
The contractor shall develop and submit within forty-five (45) calendar days of contract award, a comprehensive Supply Chain Resiliency
Program that provides identification and reporting of critical components associated with the secure supply of drug substance, drug
product, and work-in-process through to finished goods.
a) A critical component is defined as any material that is essential to the product or the manufacturing process associated with that
product. Included in the definition are consumables and disposables associated with manufacturing. NOT included in the definition are
facility and capital equipment.
Consideration of critical components includes the evaluation and potential impact of raw materials, excipients, active ingredients,
substances, pieces, parts, software, firmware, labeling, assembly, testing, analytical and environmental componentry, reagents, orutility materials which are used in the manufacturing of a drug, cell banks, seed stocks, devices and key processing components andequipment. A clear example of a critical component is one where a sole supplier is utilized.
The contractor shall identify key equipment suppliers, their locations, local resources, and the associated control processes at thetime of award. The Supply Chain Resiliency Plan shall address planning and scheduling for active pharmaceutical ingredients, upstream,
downstream, component assembly, finished drug product and delivery events as necessary for the delivery of product.
a) Communication for these requirements shall be updated as part of an annual review, or as necessary, as part of regular contractual
communications.
b) For upstream and downstream processing, both single-use and re-usable in-place processing equipment, and manufacturing disposables
also shall be addressed. For finished goods, the inspection, labeling, packaging, and associated machinery shall be addressed taking
into account capacity capabilities.
c) The focus on the aspects of resiliency shall be on critical components and aspects of complying with the contractual delivery
schedule. Delivery methods shall be addressed, inclusive of items that are foreign-sourced, both high and low volume, which would
significantly affect throughput and adherence to the contractually agreed deliveries.
The contractor shall articulate in the plan, the contractors methodology for inventory control, production planning, schedulingprocesses and ordering mechanisms, as part of those agreed deliveries.
a) Production rates and lead times shall be understood and communicated to the Contracting Officer or the Contracting Officer's
Representative as necessary.
b) Production throughput critical constraints should be well understood by activity and by design, and communicated to contractual
personnel. As necessary, communication should focus on identification, exploitation, elevation, and secondary constraints of throughput,
as appropriate.
Reports for critical items should include the following information:

CONTINUATION SHEET

Reference No. of Document Being Continued

Page 31 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
a)Critical Materialb)Vendorc)Supplier, Manufacturing / Distribution Locationd)Supplier Lead Timee)Shelf Lifef)Transportation / Shipping restrictions
The Contracting Officer or the Contracting Officer's Representative reserve the right to request un-redacted copies of technicaldocuments provided in response to this section, during the period of performance, for distribution within the Government. Documents
shall be provided within ten (10) calendar days after Contracting Officer issues the request. The Contractor may arrange for additionaltime if deemed necessary, and agreed to by the Contracting Officer.

II. Manufacturing Data Requirements
The Contractor shall submit within thirty (30) calendar days of contract award detailed data regarding project materials, sources, andmanufacturing sites, including but not limited to: physical locations of sources of raw and processed material by type of material;
location and nature of work performed at manufacturing, processing, and fill/finish sites; and location and nature of clinical studies
sites (it being understood that such information already has been provided). The Government may provide a table in tabular format forContractor to be used to submit such data which would include but not be limited to the following:-Storage/inventory of ancillary materials (vials, needles, syringes, etc.)-Shipment of ancillary materials (vials, needles, syringes, etc.)-Disposal of ancillary materials (vials, needles, syringes, etc.)-Seed development or other starting material manufacturing-Bulk drug substance and/or adjuvant production-Fill, finish, and release of product or adjuvant-Storage/inventory of starting materials, bulk substance, or filled/final product or adjuvant-Stability information of bulk substance and/or finished product-Shipment of bulk substance of final product-Disposal of bulk substance or final productIII. Product Development Source Material and Manufacturing Reports and Projections
The Contractor shall submit a detailed spreadsheet regarding critical project materials that are sourced from a location other than the
United States, sources, and manufacturing sites, including but not limited to: physical locations of sources of raw and processedmaterial by type of material; location and nature of work performed at manufacturing sites; and location and nature of clinical studies
sites.
The Contractor will provide manufacturing reports and manufacturing dose tracking projections/actuals utilizing the COVID-19 Dose
Tracking Templates, on any contract/agreement that is manufacturing product.
Reporting Procedures and Due Dates:
The Contractor shall submit a detailed spreadsheet regarding critical project materials that are sourced from a location other than the
United States, sources, and manufacturing sites, including but not limited to: physical locations of sources of raw and processedmaterial by type of material and location and nature of work performed at manufacturing sites.
The Contractor will provide manufacturing reports and manufacturing dose tracking projections/actuals utilizing the COVID-19 Dose
Tracking Templates or similar.
Reporting Procedures and Due Dates:-Contractor will submit Product Development Source Material Report-Within 1 month of contract award-Within 1 month of substantive changes made to sources and/or materials-On the 6th month contract anniversary, if no substantive changes have been made in the preceding 6 month period-The Government will provide written comments to the Product Development Source Material and Manufacturing Report within 15 businessdays after the submission-If corrective action is recommended, Contractor must address all concerns raised by the Government in writing-Product Development and Source Material report to be submitted via spreadsheet; Dose Tracking can be completed via spreadsheet or otherformat (e.g. XML or JSON) as agreed to by USG and company.
-Contractor will update the Dose Tracking Template weekly during manufacturing campaigns (b) (4)during response operations (where a
Public Health Emergency has been declared) and COVID-19 response, with the first deliverable submission within 15 calendar days of award
IV. Contractor Locations

CONTINUATION SHEET

Reference No. of Document Being Continued

Page 32 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
The contractor shall submit detailed data regarding locations where work will be performed under this contract, including addresses,
points of contact, and work performed per location, to include sub-contractors.
Contractor will submit Work Locations Report:-Within 30 business days of contract award-Within 30 business days after a substantive location or capabilities change-Within 2 business days of a substantive change if the work performed supports medical countermeasure development that addresses athreat that has been declared a Public Health Emergency by the HHS Secretary or a Public Health Emergency of International Concern(PHEIC) by the WHO
Language for SOW Security Section (or Similar)
I. Access and General Protection/Security Policy and ProceduresThis standard language text is applicable to ALL employees working on critical information related to Operation Warp Speed (OWS) with anarea of performance within a Government controlled installation, facility or area. Employees shall comply with applicable installation,
facility and area commander installation/facility access and local security policies and procedures (provided by government
representative). The performer also shall provide all information required for background checks necessary to access criticalinformation related to OWS, and to meet Government installation access requirements to be accomplished by installation Director of
Emergency Services or Security Office. The workforce must comply with all personnel identity verification requirements as directed by
the Government and/or local policy. In addition to the changes otherwise authorized by the changes clause of this agreement, should the
security status of OWS change the Government may require changes in performer security matters or processes. In addition to the industry
standards for employment background checks, the Contractor must be willing to have key individuals, in exceptionally sensitive
positions, identified for additional vetting by the United States Government.
II. Operational Security (OPSEC)
The performer shall develop an OPSEC Standard Operating Procedure (SOP)/Plan within ninety (90)-calendar-days of project award to bereviewed and approved by the responsible Government OPSEC officer. This plan will be submitted to the COR for coordination of
approvals. This SOP/Plan will include identifying the critical information related to this contract, why it needs to be protected,
where it is located, who is responsible for it, and how to protect it.
III. Security Plan
The contractor shall develop a comprehensive security program that provides overall protection of personnel, information, data, andfacilities associated with fulfilling the Government requirement. This plan shall establish security practices and procedures that
demonstrate how the contractor will meet and adhere to the security requirements outlined below prior to the commencement of productmanufacturing, and shall be delivered to the Government within 30 calendar days of award. The contractor shall also ensure all
subcontractors, consultants, researchers, etc. performing work on behalf of this effort, comply with all Government security
requirements and prime contractor security plans.
a) The Government will review in detail and submit comments within ten (10) business days to the Contracting Officer to be
forwarded to the Contractor. The Contractor shall review the Draft Security Plan comments, and, submit a Final Security Plan to the U.S.
Government within thirty (10) calendar days after receipt of the comments.
b) The Security Plan shall include a timeline for compliance of all the required security measures outlined by the Government.
c) Upon completion of initiating all security measures, the Contractor shall supply to the Contracting Officer a letter certifying
compliance to the elements outlined in the Final Security Plan.
At a minimum, the Final Security Plan shall address the following items:
Security Requirements:
1. Facility Security Plan
Description: As part of the partner facilitys overall security program, the contractor shall submit a written security plan with their
proposal to the Government for review and approval by Government security subject matter experts. The performance of work under thecontract will be in accordance with the approved security plan. The security plan will include the following processes and procedures at
a minimum:
Security Administration-organization chart and responsibilities-written security risk assessment for site-threat levels with identification matrix (High, Medium, or Low)
-enhanced security procedures during elevated threats-liaison procedures with law enforcement-annual employee security education and training program
Personnel Security-policies and procedures-candidate recruitment process-background investigations process

CONTINUATION SHEET

Reference No. of Document Being Continued

Page 33 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
-employment suitability policy-employee access determination-rules of behavior/ conduct-termination procedures-non-disclosure agreements
Physical Security Policies and Procedures-internal/external access control-protective services-identification/badging-employee and visitor access controls-parking areas and access control-perimeter fencing/barriers-product shipping, receiving and transport security procedures-facility security lighting-restricted areas-signage-intrusion detection systems-alarm monitoring/response-closed circuit television-product storage security-other control measures as identified
Information Security-identification and marking of sensitive information-access control-storage of information-document control procedures-retention/ destruction requirements
Information Technology/Cyber Security Policies and Procedures-intrusion detection and prevention systems-threat identification-employee training (initial and annual)-encryption systems-identification of sensitive information/media-password policy (max days 90)-lock screen time out policy (minimum time 20 minutes)-removable media policy-laptop policy-removal of IT assets for domestic/foreign travel-access control and determination-VPN procedures-WiFi and Bluetooth disabled when not in use-system document control-system backup-system disaster recovery-incident response-system audit procedures-property accountability

2. Site Security Master Plan
Description: The partner facility shall provide a site schematic for security systems which includes: main access points; security
cameras; electronic access points; IT Server Room; Product Storage Freezer/Room; and bio-containment laboratories.

3. Site Threat / Vulnerability / Risk Assessment
Description: The partner facility shall provide a written risk assessment for the facility addressing: criminal threat, including crime
data; foreign/domestic terrorist threat; industrial espionage; insider threats; natural disasters; and potential loss of criticalinfrastructure (power/water/natural gas, etc.) This assessment shall include recent data obtained from local law enforcement agencies.
The assessment should be updated annually.

4. Physical Security

CONTINUATION SHEET

Reference No. of Document Being Continued

Page 34 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
Description: Closed Circuit Television (CCTV) Monitoringa) Layered (internal/external) CCTV coverage with time-lapse video recording for buildings and areas where critical assets are processedor stored.
b) CCTV coverage must include entry and exits to critical facilities, perimeters, and areas within the facility deemed critical to the
execution of the contract.
c) Video recordings must be maintained for a minimum of 30 calendar days.
d) CCTV surveillance system must be on emergency power backup.
e) CCTV coverage must include entry and exits to critical facilities, perimeters, and areas within the facility deemed critical to the
execution of the contract.
f) Video recordings must be maintained for a minimum of 30 calendar days.
g) CCTV surveillance system must be on emergency power backup.
Facility Lightinga) Lighting must cover facility perimeter, parking areas, critical infrastructure, and entrances and exits to buildings.
b) Lighting must have emergency power backup.
c) Lighting must be sufficient for the effective operation of the CCTV surveillance system during hours of darkness.
Shipping and Receivinga)Must have CCTV coverage and an electronic access control system.
b)Must have procedures in place to control access and movement of drivers picking up or delivering shipments.
c)Must identify drivers picking up Government products by government issued photo identification.
Access Controla) Must have an electronic intrusion detection system with centralized monitoring.
b) Responses to alarms must be immediate and documented in writing.
c) Employ an electronic system (i.e., card key) to control access to areas where assets critical to the contract are located(facilities, laboratories, clean rooms, production facilities, warehouses, server rooms, records storage, etc.).
d) The electronic access control should signal an alarm notification of unauthorized attempts to access restricted areas.
e) Must have a system that provides a historical log of all key access transactions and kept on record for a minimum of12 months.
f) Must have procedures in place to track issuance of access cards to employees and the ability to deactivate cards when they are lostor an employee leaves the company.
g) Response to electronic access control alarms must be immediate and documented in writing and kept on record for a minimum of 12months.
h) Should have written procedures to prevent employee piggybacking accessi) to critical infrastructure (generators, air handlers, fuel storage, etc.) should be controlled and limited to those with a legitimate
need for access.
j) Must have a written manual key accountability and inventory process.
k) Physical access controls should present a layered approach to critical assets within the facility.
Employee/Visitor Identificationa) Should issue company photo identification to all employees.
b) Photo identification should be displayed above the waist anytime the employee is on company property.
c) Visitors should be sponsored by an employee and must present government issued photo identification to enter the property.
d) Visitors should be logged in and out of the facility and should be escorted by an employee while on the premises at all times.
Security Fencing
Requirements for security fencing will be determined by the criticality of the program, review of the security plan, threat assessment,
and onsite security assessment.
Protective Security Forces
Requirements for security officers will be determined by the criticality of the program, review of the security plan, threat assessment,
and onsite security assessment.
Protective Security Forces Operationsa) Must have in-service training program.
b) Must have Use of Force Continuum.
c) Must have communication systems available (i.e., landline on post, cell phones, handheld radio, and desktop computer).
d) Must have Standing Post Orders.
e) Must wear distinct uniform identifying them as security officers.

5. Security Operations
Description: Information Sharinga) Establish formal liaison with law enforcement.
b) Meet in person at a minimum annually. Document meeting notes and keep them on file for a, minimum of 12 months. POC information forCONTINUATION SHEET

Reference No. of Document Being Continued

Page 35 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
LE Officer that attended the meeting must be documented.
c) Implement procedures for receiving and disseminating threat information.
Traininga) Conduct new employee security awareness training.
b) Conduct and maintain records of annual security awareness training.
Security Managementa) Designate a knowledgeable security professional to manage the security of the facility.
b) Ensure subcontractor compliance with all Government security requirements.

6. Personnel Security
Description:
Records Checks
Verification of social security number, date of birth, citizenship, education credentials, five-year previous employment history, fiveyear previous residence history, FDA disbarment, sex offender registry, credit check based upon position within the company; motor
vehicle records check as appropriate; and local/national criminal history search.
Hiring and Retention Standardsa) Detailed policies and procedures concerning hiring and retention of employees, employee conduct, and off boarding procedures.
b) Off Boarding procedures should be accomplished within 24 hour of employee leaving the company. This includes termination of all
network access.

7. Information Security
Description:
Physical Document Controla) Applicable documents shall be identified and marked as procurement sensitive, proprietary, or with appropriate government markings.
b) Sensitive, proprietary, and government documents should be maintained in a lockable filing cabinet/desk or other storage device andnot be left unattended.
c) Access to sensitive information should be restricted to those with a need to know.
Document Destruction
Documents must be destroyed using approved destruction measures (i.e, shredders/approved third party
vendors / pulverizing / incinerating).

8. Information Technology & Cybersecurity
Description:
Identity Managementa) Physical devices and systems within the organization are inventoried and accounted for annually.
b) Organizational cybersecurity policy is established and communicated.
c) Asset vulnerabilities are identified and documented.
d) Cyber threat intelligence is received from information sharing forums and sources.
e) Threats, vulnerabilities, likelihoods, and impacts are used to determine risk.
f) Identities and credentials are issued, managed, verified, revoked, and audited for authorized devices, users and processes.
g) Users, devices, and other assets are authenticated (e.g., single-factor, multifactor) commensurate with the risk of the transaction(e.g., individuals security and privacy risks and other organizational risks)
Access Controla) Limit information system access to authorized users.
b) Identify information system users, processes acting on behalf of users, or devices and authenticate identities before allowing
access.
c) Limit physical access to information systems, equipment, and server rooms with electronic access controls.
d) Limit access to/ verify access to use of external information systems.
Traininga) Ensure that personnel are trained and are made aware of the security risks associated with their activities and of the applicablelaws, policies, standards, regulations, or procedures related to information technology systems.
Audit and Accountabilitya) Create, protect, and retain information system audit records to the extent needed to enable the monitoring, analysis, investigation,and reporting of unlawful, unauthorized, or inappropriate system activity. Records must be kept for minimum must be kept for 12 months.

CONTINUATION SHEET

Reference No. of Document Being Continued

Page 36 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
b) Ensure the actions of individual information system users can be uniquely traced to those users.
c) Update malicious code mechanisms when new releases are available.
d) Perform periodic scans of the information system and real time scans of files from external sources as files are downloaded, opened,or executed.
Configuration Managementa) Establish and enforce security configuration settings.
b) Implement sub networks for publically accessible system components that are physically or logically separated from internal networks.

Contingency Planninga) Establish, implement, and maintain plans for emergency response, backup operations, and post-disaster recovery for information
systems to ensure the availability of critical information resources at all times.
Incident Responsea) Establish an operational incident handling capability for information systems that includes adequate preparation, detection,
analysis, containment, and recovery of cybersecurity incidents. Exercise this capability annually.
Media and Information Protectiona) Protect information system media, both paper and digital.
b) Limit access to information on information systems media to authorized users.
c) Sanitize and destroy media no longer in use.
d) Control the use of removable media through technology or policy.
Physical and Environmental Protectiona) Limit access to information systems, equipment, and the respective operating environments to authorized individuals.
b) Intrusion detection and prevention system employed on IT networks.
c) Protect the physical and support infrastructure for all information systems.
d) Protect information systems against environmental hazards.
e) Escort visitors and monitor visitor activity.
Network Protection
Employ intrusion prevention and detection technology with immediate analysis capabilities.

9. Transportation Security
Description: Adequate security controls must be implemented to protect materials while in transit from theft, destruction, manipulation,
or damage.
Driversa) Drivers must be vetted in accordance with Government Personnel Security Requirements.
b) Drivers must be trained on specific security and emergency procedures.
c) Drivers must be equipped with backup communications.
d) Driver identity must be 100 percent confirmed before the pick-up of any Government product.
e) Drivers must never leave Government products unattended, and two drivers may be required for longer transport routes or criticalproducts during times of emergency.
f) Truck pickup and deliveries must be logged and kept on record for a minimum of 12 months.
Transport Routesa) Transport routes should be pre-planned and never deviated from except when approved or in the event of an emergency.
b) Transport routes should be continuously evaluated based upon new threats, significant planned events, weather, and other situations
that may delay or disrupt transport.
Product Securitya) Government products must be secured with tamper resistant seals during transport, and the transport trailer must be locked andsealed.
Tamper resistant seals must be verified as secure after the product is placed in the transport vehicle.
b) Government products should be continually monitored by GPS technology while in transport, and any deviations from planned routes
should be investigated and documented.
c) Contingency plans should be in place to keep the product secure during emergencies such as accidents and transport vehicle
breakdowns.

10. Security Reporting Requirements
Description: The partner facility shall notify the Government Security Team within 24 hours of any activity or incident that is inviolation of established security standards or indicates the loss or theft of government products. The facts and circumstances

CONTINUATION SHEET

Reference No. of Document Being Continued

Page 37 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
associated with these incidents will be documented in writing for government review.

11. Security Audits
Description: The partner facility agrees to formal security audits conducted at the discretion of the government. Security audits may
include both prime and subcontractor.

*** END OF NARRATIVE F0001 ***CONTINUATION SHEET

Reference No. of Document Being Continued

Page 38 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
CONTRACT ADMINISTRATION DATA

LINE
ITEM
_____
0001AAPRON/AMS CD/MIPR/
GFEBS ATA_________
CB1RD45726

OBLG
STAT
_____
2

JO NO/
ACCT ASSIGN___________
S.0074658.5.31.1

ACRN
____
AA

$

(b) (4)0001AB

CB1RD26995

2

S.0074658.5.31

AB$(b) (4)0002AA

CB1RD60238

2

S.0074658.5.31.2

AC$(b) (4)0002AB

CB1RD59428

2

S.0074658.5.31.3

AD$(b) (4)0003

CB1RD47628

2

S.0074658.5.31.2

AE$(b) (4)

OBLIGATEDAMOUNT__________

TOTAL

ACRN
____
AA
AB
AC
AD
AE

ACCOUNTING CLASSIFICATION_________________________
021 202120222040
A5XAH 654807849FL8D
021 202120222040
A5XAH 654807849FL8D
021 202120222040
A5XAH 654807849FL8D
021 202120222040
A5XAH 654807849FL8D
021 202120222040
A5XAH 654807849FL8D__________________
2,011,282,500.00$

OBLIGATED__________AMOUNT
255Y L071245726 S.0074658.5.31.1
255Y L071226995 S.0074658.5.31
255Y L071260238 S.0074658.5.31.2
255Y L071259428 S.0074658.5.31.3
255Y L071247628 S.0074658.5.31.2

021001 $(b) (4)021001 $(b) (4)021001 $(b) (4)021001 $(b) (4)021001 $_____(b) (4)
TOTAL

LINE
ITEM
_____
0001AA
0001AB
0002AA
0002AB
0003

ACRN
____
AA
AB
AC
AD
AE

EDI/SFIS ACCOUNTING CLASSIFICATION__________________________________
021 202120222040
A5XAH 654807849FL8D
021 202120222040
A5XAH 654807849FL8D
021 202120222040
A5XAH 654807849FL8D
021 202120222040
A5XAH 654807849FL8D
021 202120222040
A5XAH 654807849FL8D
Regulatory Cite_______________$

255Y L071245726 S.0074658.5.31.1
255Y L071226995 S.0074658.5.31
255Y L071260238 S.0074658.5.31.2
255Y L071259428 S.0074658.5.31.3
255Y L071247628 S.0074658.5.31.2______________________________________________________________________
Title

1
252.232-7006
WIDE AREA WORKFLOW PAYMENT INSTRUCTIONS(a) Definitions. As used in this clause--

2,011,282,500.00

021001021001021001021001021001____________
Date
DEC/2018"Department of Defense Activity Address Code (DoDAAC)" is a six position code that uniquely identifies a unit, activity, ororganization.
"Document type" means the type of payment request or receiving report available for creation in Wide Area WorkFlow (WAWF).
"Local processing office (LPO)" is the office responsible for payment certification when payment certification is done external to theentitlement system.
"Payment request" and "receiving report" are defined in the clause at 252.232-7003, Electronic Submission of Payment Requests andReceiving Reports.
(b) Electronic invoicing. The WAWF system provides the method to electronically process vendor payment requests and receiving reports,
as authorized by Defense Federal Acquisition Regulation Supplement (DFARS) 252.232-7003, Electronic Submission of Payment Requests andReceiving Reports.
(c) WAWF access. To access WAWF, the Contractor shall--CONTINUATION SHEET

Reference No. of Document Being Continued

Page 39 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
(1) Have a designated electronic business point of contact in the System for Award Management at https://www.sam.gov(2) Be registered to use WAWF at https://wawf.eb.mil/
Web site.

; andfollowing the step-by-step procedures for self-registration available at this(d) WAWF training. The Contractor should follow the training instructions of the WAWF Web-Based Training Course and use the PracticeTraining Site before submitting payment requests through WAWF. Both can be accessed by selecting the "Web Based Training" link on the
WAWF home page at https://wawf.eb.mil/ .
(e) WAWF methods of document submission. Document submissions may be via Web entry, Electronic Data Interchange, or File Transfer
Protocol.
(f) WAWF payment instructions. The Contractor shall use the following information when submitting payment requests and receiving reports
in WAWF for this contract or task or delivery order:(1) Document type. The Contractor shall submit payment requests using the following document type(s):(i) For cost-type line items, including labor-hour or time-and-materials, submit a cost voucher.
(ii) For fixed price line items-(A) That require shipment of a deliverable, submit the invoice and receiving report specified by the Contracting Officer.
Invoice (Contractor Only)(B) For services that do not require shipment of a deliverable, submit either the Invoice 2in1, which meets the requirements forthe invoice and receiving report, or the applicable invoice and receiving report, as specified by the Contracting Officer.
Invoice as 2-in-1(iii) For customary progress payments based on costs incurred, submit a progress payment request.
(iv) For performance based payments, submit a performance based payment request.
(v) For commercial item financing, submit a commercial item financing request.
(2) Fast Pay requests are only permitted when Federal Acquisition Regulation (FAR) 52.213-1 is included in the contract.
[Note: The Contractor may use a WAWF "combo" document type to create some Combinations of invoice and receiving report in one step.](3) Document routing. The Contractor shall use the information in the Routing Data Table below only to fill in applicable fields in
WAWF when creating payment requests and receiving reports in the system.
Routing Data Table*-----------------------------------------------------------------------Field Name in WAWF
Data to be entered in WAWF-----------------------------------------------------------------------Pay Official DoDAAC
HQ0337
Issue By DoDAAC
W15QKN
Admin DoDAAC
W15QKN
Inspect By DoDAAC
W90ZQ2
Ship To Code
TBD
Ship From Code
TBDMark For Code
TBD
Service Approver (DoDAAC)
N/A
Service Acceptor (DoDAAC)
N/A
Accept at Other DoDAAC
N/A
LPO DoDAAC
N/A
DCAA Auditor DoDAAC
N/A
Other DoDAAC(s)N/A-----------------------------------------------------------------------(4) Payment request. The Contractor shall ensure a payment request includes documentation appropriate to the type of payment request
in accordance with the payment clause, contract financing clause, or Federal Acquisition Regulation 52.216-7, Allowable Cost andPayment, as applicable.

CONTINUATION SHEET

Reference No. of Document Being Continued

Page 40 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
(5) Receiving report. The Contractor shall ensure a receiving report meets the requirements of DFARS Appendix F.
(g) WAWF point of contact.
(1) The Contractor may obtain clarification regarding invoicing in WAWF from the following contracting activity's WAWF point ofcontact.
(b) (6)@mail.mil(2) Contact the WAWF helpdesk at 866-618-5988, if assistance is needed.
(End of clause)

CONTINUATION SHEET

Reference No. of Document Being Continued

Page 41 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
SPECIAL CONTRACT REQUIREMENTS
MANDATORY OPSEC CLAUSE
I. _________________________
Disclosure of Information
Performance under this contract may require the Contractor to access non-public data and information proprietary to a Government
agency, another Government contractor or of such nature that its dissemination or use other than as specified in the work statement
would be adverse to the interests of the Government or others. Neither the Contractor, nor Contractor personnel, shall divulge nor
release data nor information obtained under performance of this contract, except authorized by Government personnel or upon written
approval of the Contracting Officer in accordance with OWS or other Government policies and/or guidance. The Contractor shall not use,
disclose, or reproduce proprietary data that bears a restrictive legend, other than as specified in this contract, or any information at
all regarding this agency.
The Contractor shall comply with all Government requirements for protection of non-public information. Unauthorized disclosure of
nonpublic information is prohibited by the Governments rules. Unauthorized disclosure may result in termination of the contract,
replacement of a Contractor employee, or other appropriate redress. Neither the Contractor nor the Contractors employees shall discloseor cause to be disseminated, any information concerning the operations of the activity, which could result in, or increase thelikelihood of, the possibility of a breach of the activitys security or interrupt the continuity of its operations.
II. RESERVED
III. __________________________
Publications and Publicity
A. Neither Pfizer nor the Government shall make, or permit any person to make, any public announcement concerning the existence, subject
matter or terms of this Contract, the transactions contemplated by it, or the relationship between Pfizer and the Government hereunder,
without the prior written consent of the other, such consent not to be unreasonably withheld or delayed, except as required by law, any
governmental or regulatory authority (including, without limitation, any relevant securities exchange), any court or other authority ofcompetent jurisdiction.
(b) (4).
C. Unless authorized in writing by the Contracting Officer, Pfizer shall not display Government logos including Operating Division or
Staff Division logos on any publications. Unless authorized in writing by Pfizer, the Government shall not display Pfizer logos on any
publications.
D. Pfizer shall not reference the products(s) or services(s) awarded under this contract in commercial advertising, as defined in FAR
31.205-1, in any manner which states or implies Government approval or endorsement of the product(s) or service(s) provided.
IV. ______________________________
Confidentiality of Information
A. Confidential Information, as used in this Article, means information or data of a personal nature about an individual, or proprietary
information or data submitted by or pertaining to an institution or organization.
B. The Contracting Officer and Pfizer may, by mutual consent, identify elsewhere in this Contract specific information and/or
categories of information which the Government will furnish to Pfizer or that Pfizer is expected to generate which is confidential.
Similarly, the Contracting Officer and Pfizer may, by mutual consent, identify such Confidential Information from time to time during
the Period of Performance. Failure to agree will be settled pursuant to FAR 52.233-1 the Disputes clause.
C. If it is established elsewhere in this Contract that information to be utilized under this Contract, or a portion thereof, is subject
to the Privacy Act, Pfizer will follow the rules and procedures of disclosure set forth in the Privacy Act of 1974, 5 U.S.C. 552a, andimplementing regulations and policies, with respect to systems of records determined to be subject to the Privacy Act.
D. The Receiving Party shall not directly or indirectly, divulge or reveal to any person or entity any Confidential Information ofanother Party without the Disclosing Partys prior written consent, or use such Confidential Information except as permitted under thisContract. Confidential Information shall be subject to the same prohibitions on disclosure as provided for under FAR Part 24.202.
Further, any reproduction of Confidential Information or portions thereof that is disseminated within the Government, CMF, or Pfizer,
shall be shared strictly on a need to know basis for the purposes of this Contract and is subject to the restrictions of this provision.
In addition to the above, Confidential Information is subject to the protections of the Trade Secrets Act as well as any other remedies
available under this Contract or the law.
E. Such obligation of confidentiality shall not apply to information which the Receiving Party can demonstrate through competentevidence: (i) was at the time of disclosure in the public domain; (ii) has come into the public domain after disclosure through nobreach of this contract; (iii) was known to the Receiving Party prior to disclosure thereof by the Disclosing Party; (iv) was lawfully
disclosed to the Receiving Party by a Third Party which was not under an obligation of confidence to the Disclosing Party with respect
thereto; (v) was approved for public release by prior written permission of the Disclosing Party; or (vi) required by law or regulation
to be disclosed, provided, however, that the Receiving Party has provided written notice to the disclosing party promptly so as toenable such disclosing party to seek a protective order or otherwise prevent disclosure of such information.

CONTINUATION SHEET

Reference No. of Document Being Continued

Page 42 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
F. Whenever Pfizer is uncertain with regard to the proper handling of material under the Contract, or if the material in question is
subject to the Privacy Act or is Confidential Information subject to the provisions of this Article, Pfizer shall obtain a written
determination from the Contracting Officer prior to any release, disclosure, dissemination, or publication.
G. Contracting Officer Determinations will reflect the result of internal coordination with appropriate program and legal officials.
H. The provisions of paragraph (D) of this Article shall not apply to conflicting or overlapping provisions in other Federal, State or
local laws.
I. The obligations of the Receiving Party under this Article shall continue for a period of (b) (4)Confidential Information.

from conveyance of the*** END OF NARRATIVE H0001 ***Addenda to FAR 52.212-4
Not withstanding the indication of NONE in Block 1 of the SF1449, this is a rated order. The rating is DO HR.
HEALTH RESOURCE PRIORITY AND ALLOCATIONS SYSTEM (HRPAS)
In order to ensure the success of Pfizer's efforts, a priority rating is incorporated into the contract for the procurement of raw
materials, consumables, repair parts, and major end item assemblies by Pfizer under Title I of the HRPAS.
Priority Rating: Defense Production Act (DPA) Title I DO-HR
Each rated order executed by Pfizer must include the following:(a) The priority rating: DPA Title I DO-HR;(b) A required delivery date or dates. The words immediately or as soon as possible do not constitute a delivery date;(c) The written signature on a manually placed order, or the digital signature or name on an electronically placed order, of anindividual authorized to sign rated orders for the person placing the order; and(d) A statement that reads in substance:(1) This is a rated order certified for national defense use, and you are required to follow all the provisions of the HealthResources Priorities and Allocations System regulation at 45 CFR part 101.
(2) If the rated order is placed in support of emergency preparedness requirements and expedited action is necessary andappropriate to meet these requirements, the following sentences should be added following the statement set forth in paragraph (d)(1) of
this section:(i) This rated order is placed for the purpose of emergency preparedness. It must be accepted or rejected within two (2) days
after receipt of the order if:
A. The order is issued in response to a hazard that has occurred; or
B. If the order is issued to prepare for an imminent hazard, as specified in HRPAS Section 101.33(e)Addendum to FAR 52.212-4(m): The following language is hereby incorporated into clause FAR 52.212-4, Terms and Conditions - Commercial
Items, subparagraph (m), Termination for Cause: If the Government contemplates a termination for cause, the contracting officer shallgive the contractor written notice specifying the failure and providing a period of 30 days (or longer period as necessary) in which tocure the failure. Upon expiration of the 30 days (or longer period), the contracting officer may issue a notice of termination fordefault unless it is determined that the failure to perform has been cured.
(b) (4)

CONTINUATION SHEET

Reference No. of Document Being Continued

Page 43 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
(b) (4)(b) (4)

Addendum to FAR 52.212-4(p): The following language is hereby incorporated into clause FAR 52.212-4, Terms and Conditions - Commercial
Items, subparagraph (p), Limitation of Liability:
In addition to the protections afforded under the PREP Act discussed above, the Contractor will not be liable to the Government forconsequential damages resulting from any defect or deficiencies in accepted items. Except for Pfizers obligation to pay any amounts that
become due and payable to McKesson by Pfizer pursuant to the terms of the Pfizer/McKesson agreement governing the kits, Pfizer shallhave no liability whatsoever for any action or failure by McKesson to assemble, ship, or otherwise deliver kits. Pfizer will, however,retain risk of physical loss of diluent provided to McKesson until the ship-to site accepts delivery of the kit, and, in the event of
any such loss, will provide an equal number of replacement vials of diluent to McKesson for kitting at no additional cost to theGovernment. The Government agrees and acknowledges that the kits and their components (including, without limitation, the diluent) will
be used to enable administration of the vaccine. It is expected that the ship-to sites will contact McKessons customer service in theevent that a ship-to site receives a kit that is defective, damaged, or if there is a shortage in the number of kits received.
(b) (4)

The following language is added as addenda to FAR 52.212-4:
Excusable Delays Due to COVID-19
The parties recognize that the global pandemic caused by COVID-19 has had a significant impact on the availability of certain suppliers
and other resources necessary to produce certain pharmaceutical and related products, including the diluent. Accordingly,
notwithstanding any provision to the contrary herein, the Contractor shall not be liable for default if nonperformance is caused by anoccurrence beyond the reasonable control of the Contractor and without its fault or negligence, as contemplated in FAR 52.212-4(f). For
avoidance of doubt, occurrences beyond the reasonable control of the Contractor and without its fault or negligence also include supply
chain disruptions arising from or related to the COVID-19 pandemic and the availability of materials for performance of this Contract.
In the event of an excusable delay caused by a supply chain disruption arising from or related to the COVID-19 pandemic and theavailability of materials for performance of this Contract, Contractor shall follow the procedures at FAR 52.212-4(f).
(b) (4)Controlled Unclassified Information (CUI)
To the extent there is CUI delivered under the contract, it will be (1) clearly labeled by the Government and (2) sent only to a
designated secure reading room for which Pfizer will provide the Government with instructions and contact information. Additionally, CUI
obtained will only be within limited categories, agreed by the parties prior to any exchange of CUI under the agreement, and under nocircumstances will ITAR export-controlled information be provided to Pfizer. Pfizer shall handle CUI in accordance with company practiceapplied to commercial confidential information. For purposes of this contract, handling of CUI in accordance with Contractor practiceis deemed to satisfy the requirements of DFARS 252.204-7012.
PREP ActIn accordance with the Public Readiness and Emergency Preparedness Act (PREP Act), Pub. L. No. 109-148, Division C, Section 2, as
amended (codified at 42 U.S.C. \'a7 247d-6d and 42 U.S.C. \'a7 247d-6e), as well as the Secretary of HHSs Declaration Under the Public
Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19, 85 Fed. Reg. 15198 (Mar. 17, 2020, effective Feb.
4, 2020), and amended on April 15, 2020, 85 Fed. Reg. 21012, and on June 8, 2020, 85 Fed. Reg 34740 and on August 24, 2020, 85 Fed. Reg
52136 (together, the Prep Act Declaration):(i)This Agreement is being entered into for purposes of facilitating the manufacture, testing, development, distribution,
administration, and use of Covered Countermeasures for responding to the COVID-19 public health emergency, in accordance with Section VI
of the PREP Act Declaration;

Reference No. of Document Being Continued

CONTINUATION SHEET

Page 44 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
(ii)
Pfizers performance of this Agreement falls within the scope of the Recommended Activities for responding to the COVID19 public health emergency in accordance with Section III of the PREP Act Declaration; and(iii)

Pfizer is a Covered Person per Section V of the PREP Act Declaration.

Therefore, in accordance with Sections IV and VII of the PREP Act Declaration as well as the PREP Act (42 U.S.C. Section 247d-6d), theDepartment of Defense contracting via assisted acquisition on behalf of the HHS, expressly acknowledges and agrees that the Prep Act
Declaration cited above, specifically its language providing immunity from suit and liability is applicable to this Agreement, as longas Pfizers activities fall within the terms and conditions of the PREP Act and the PREP Act Declaration.
The Government may not use, or authorize the use of, any products or materials provided under this Agreement or that are provided inconnection with the administration of the Pfizer vaccine, unless such use occurs in the United States (or a U.S. territory where U.S.
law applies including, but not limited to, embassies, military installations and NATO installations) and is protected from liability
under a declaration issued under the PREP Act, or a successor COVID-19 PREP Act declaration of equal or greater scope. Any use where theapplication of the PREP Act is in question will be discussed with Pfizer prior to use and, if the Parties disagree on such use, thedispute will be resolved according to FAR 52.212-4(d).
Government Program Pricing
The price per dose in this contract was established per Operation Warp Speed and in light of the COVID-19 pandemic, and thus is specificto this contract only. This price shall not serve as the basis for pricing under any separate government contracts between Pfizer and
HHS, the Department of Defense, or any other Department or agency of the Government by application of most favored customer, mostfavored nation, or any other contract or program-specific terms.

Inspection and Acceptance Section Clause Addenda
For the purposes of this contract, FAR 52.246-2 and FAR 52.246-16 are superseded in their entirety by SOW Section C.6.
Addenda to DFARS 252.204-7003
This contract does not include the acquisition of "government personnel work product" per DFARS 252.204-7003.

(b) (4)*** END OF NARRATIVE H0002 ***CONTINUATION SHEET

Reference No. of Document Being Continued

Page 45 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
CONTRACT CLAUSES

1
2
3
4
5
6
7
8
9
10
11

Regulatory Cite_______________
52.204-13
52.204-18
52.212-4
52.232-40
252.203-7000
252.203-7002
252.203-7003
252.204-7003
252.204-7012
252.204-7015
252.204-7018

1213252.205-7000
252.209-7004

14
15
16

252.225-7012
252.232-7010
252.232-7017

17
18
19

252.243-7002
252.244-7000
252.247-7023

20

52.212-5______________________________________________________________________Title
SYSTEM FOR AWARD MANAGEMENT MAINTENANCECOMMERCIAL AND GOVERNMENT ENTITY CODE MAINTENANCE
CONTRACT TERMS AND CONDITIONS--COMMERCIAL ITEMSPROVIDING ACCELERATED PAYMENTS TO SMALL BUSINESS SUBCONTRACTORSREQUIREMENTS RELATING TO COMPENSATION OF FORMER DOD OFFICIALSREQUIREMENT TO INFORM EMPLOYEES OF WHISTLEBLOWER RIGHTSAGENCY OFFICE OF THE INSPECTOR GENERALCONTROL OF GOVERNMENT PERSONNEL WORK PRODUCTSAFEGUARDING COVERED DEFENSE INFORMATION AND CYBER INCIDENT REPORTINGNOTICE OF AUTHORIZED DISCLOSURE OF INFORMATION FOR LITIGATION SUPPORTPROHIBITION ON THE ACQUISITION OF COVERED DEFENSE TELECOMMUNICATIONSEQUIPMENT OR SERVICESPROVISION OF INFORMATION TO COOPERATIVE AGREEMENT HOLDERSSUBCONTRACTING WITH FIRMS THAT ARE OWNED OR CONTROLLED BY THE
GOVERNMENT OF A TERRORIST COUNTRY
PREFERENCE FOR CERTAIN DOMESTIC COMMODITIESLEVIES ON CONTRACT PAYMENTS
ACCELERATING PAYMENTS TO SMALL BUSINESS SUBCONTRACTORS--PROHIBITION
ON FEES AND CONSIDERATIONREQUESTS FOR EQUITABLE ADJUSTMENTSUBCONTRACTS FOR COMMERCIAL ITEMSTRANSPORTATION OF SUPPLIES BY SEA--BASIC____________
Date
OCT/2018
AUG/2020
OCT/2018
DEC/2013
SEP/2011
SEP/2013
AUG/2019
APR/1992
DEC/2019
MAY/2016
DEC/2019
DEC/1991
MAY/2019
DEC/2017
DEC/2006
APR/2020
DEC/2012
OCT/2020
FEB/2019

CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT STATUTES OR
NOV/2020
EXECUTIVE ORDERS--COMMERCIAL ITEMS(a) The Contractor shall comply with the following Federal Acquisition Regulation (FAR) clauses, which are incorporated in this contract
by reference, to implement provisions of law or Executive orders applicable to acquisitions of commercial items:(1) 52.203-19, Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements (JAN 2017) (section 743 of Division
E, Title VII, of the Consolidated and Further Continuing Appropriations Act, 2015 (Pub. L. 113-235) and its successor provisions insubsequent appropriations acts (and as extended in continuing resolutions)).
(2) 52.204-23, Prohibition on Contracting for Hardware, Software, and Services Developed or Provided by Kaspersky Lab and Other
Covered Entities (Jul 2018) (Section 1634 of Pub. L. 115-91).
(3) 52.204-25, Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment. (AUG 2020)(Section 889(a)(1)(A) of Pub. L. 115-232).
(4) 52.209-10, Prohibition on Contracting with Inverted Domestic Corporations (Nov 2015)(5) 52.233-3, Protest After Award (AUG 1996) (31 U.S.C. 3553).
(6) 52.233-4, Applicable Law for Breach of Contract Claim (OCT 2004) (Public Laws 108-77 and 108-78 (19 U.S.C. 3805 note)).
(b) The Contractor shall comply with the FAR clauses in this paragraph (b) that the contracting officer has indicated as being
incorporated in this contract by reference to implement provisions of law or Executive orders applicable to acquisitions of commercial
items:___ (1) 52.203-6, Restrictions on Subcontractor Sales to the Government (Jun 2020), with Alternate I (Oct 1995)(41 U.S.C. 4704 and10 U.S.C. 2402).
_X__ (2) 52.203-13, Contractor Code of Business Ethics and Conduct (Jun 2020) (41 U.S.C. 3509).
___ (3) 52.203-15, Whistleblower Protections under the American Recovery and Reinvestment Act of 2009 (Jun 2010) (Section 1553 ofPub. L. 111-5). (Applies to contracts funded by the American Recovery and Reinvestment Act of 2009.)_X__ (4) 52.204-10, Reporting Executive Compensation and First-Tier Subcontract Awards (Jun 2020) (Pub. L. 109-282) (31 U.S.C. 6101
note).
___ (5) [Reserved].
____ (6) 52.204-14, Service Contract Reporting Requirements (Oct 2016) (Pub. L. 111-117, section 743 of Div. C).

Reference No. of Document Being Continued

CONTINUATION SHEET

Page 46 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
___ (7) 52.204-15, Service Contract Reporting Requirements for Indefinite-Delivery Contracts (Oct 2016) (Pub. L. 111-117, section
743 of Div. C).
___ (8) 52.209-6, Protecting the Government's Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for
Debarment (Jun 2020) (31 U.S.C. 6101 note).
___ (9) 52.209-9, Updates of Publicly Available Information Regarding Responsibility Matters (Oct 2018) (41 U.S.C. 2313).
___ (10) [Reserved]___ (11)(i) 52.219-3, Notice of HUBZone Set-Aside or Sole-Source Award (MAR 2020) (15 U.S.C. 657a).
___ (ii) Alternate I (MAR 2020) of 52.219-3.
___ (12)(i) 52.219-4, Notice of Price Evaluation Preference for HUBZone Small Business Concerns (MAR 2020) (if the offeror elects towaive the preference, it shall so indicate in its offer) (15 U.S.C. 657a).
___ (ii) Alternate I (MAR 2020) of 52.219-4.
___ (13) [Reserved]___ (14)(i) 52.219-6, Notice of Total Small Business Set-Aside (Nov 2020) (15 U.S.C. 644).
___ (ii) Alternate I (MAR 2020) of 52.219-6.
___ (iii) Alternate II (Nov 2011) of 52.219-6.
___ (15)(i) 52.219-7, Notice of Partial Small Business Set-Aside (Nov 2020)(15 U.S.C. 644).
___ (ii) Alternate I (MAR 2020) of 52.219-7.
___ (iii) Alternate II (Mar 2004) of 52.219-7.
___ (16) 52.219-8, Utilization of Small Business Concerns (Oct 2018) (15 U.S.C. 637(d)(2) and (3)).
_X__ (17)(i) 52.219-9, Small Business Subcontracting Plan (Jun 2020) (15 U.S.C. 637(d)(4)).
___ (ii) Alternate I (Nov 2016) of 52.219-9.
___ (iii) Alternate II (Nov 2016) of 52.219-9.
___ (iv) Alternate III (Jun 2020) of 52.219-9.
___ (v) Alternate IV (Jun 2020) of 52.219-9.
___ (18)(i) 52.219-13, Notice of Set-Aside of Orders (MAR 2020) (15 U.S.C. 644(r)).
___ (ii) Alternate I (Mar 2020) of 52.219-13.
___ (19) 52.219-14, Limitations on Subcontracting (MAR 2020)(15 U.S.C. 637(a)(14)).
___ (20) 52.219-16, Liquidated Damages--Subcontracting Plan (JAN 1999) (15 U.S.C. 637(d)(4)(F)(i)).
___ (21) 52.219-27, Notice of Total Service-Disabled Veteran-Owned Small Business Set-Aside (MAR 2020)(15 U.S.C. 657 f)___ (22) (i) 52.219-28, Post Award Small Business Program Rerepresentation (Nov 2020)(15 U.S.C. 632(a)(2)).
___ (ii) Alternate I (MAY 2020) of 52.219-28.
___ (23) 52.219-29 Notice of Total Set-Aside for Economically Disadvantaged Women-Owned Small Business (EDWOSB) Concerns (MAR 2020)(15 U.S.C. 637(m)).
___ (24) 52.219-30 Notice of Total Set-Aside for Women-Owned Small Business (WOSB) Concerns Eligible Under the WOSB Program (MAR2020) (15 U.S.C. 637(m)).

Reference No. of Document Being Continued

CONTINUATION SHEET

Page 47 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
___ (25) 52.219-32, Orders Issued Directly Under Small Business Reserves (MAR 2020) (15 U.S.C. 644(r)).
___ (26) 52.219-33, Nonmanufacturer Rule (MAR 2020) (15 U.S.C. 637(a)(17)).
___ (27) 52.222-3, Convict Labor (June 2003)(E.O. 11755).
___ (28) 52.222-19, Child LaborCooperation with Authorities and Remedies (Jan 2020) (E.O. 13126).
___ (29) 52.222-21, Prohibition of Segregated Facilities (Apr 2015).
_X__ (30)(i) 52.222-26, Equal Opportunity (Sep 2016)(E.O. 11246).
___ (ii) Alternate I (Feb 1999) of 52.222-26.
___ (31)(i) 52.222-35, Equal Opportunity for Veterans (Jun 2020)(38 U.S.C. 4212).
___ (ii) Alternate I (July 2014) of 52.222-35.
___ (32)(i) 52.222-36, Equal Opportunity for Workers with Disabilities (Jun 2020)(29 U.S.C. 793).
___ (ii) Alternate I (July 2014) of 52.222-36.
___ (33) 52.222-37, Employment Reports on Special Disabled Veterans, Veterans of the Vietnam Era, and Other Eligible Veterans (Jun2020)(38 U.S.C. 4212).
___ (34) 52.222-40, Notification of Employee Rights Under the National Labor Relations Act (Dec 2010) (E.O. 13496).
___ (35)(i) 52.222-50, Combating Trafficking in Persons (Oct 2020) (22 U.S.C. chapter 78 and E.O. 13627).
___ (ii) Alternate I (Mar 2015) of 52.222-50 (22 U.S.C. chapter 78 and E.O. 13627).
___ (36) 52.222-54, Employment Eligibility Verification (Oct 2015). (Executive Order 12989). (Not applicable to the acquisition ofcommercially available off-the-shelf items or certain other types of commercial items as prescribed in 22.1803.)___ (37)(i) 52.223-9, Estimate of Percentage of Recovered Material Content for EPA-Designated Items (May 2008) (42 U.S.C.
6962(c)(3)(A)(ii)). (Not applicable to the acquisition of commercially available off-the-shelf items.)___ (ii) Alternate I (May 2008) of 52.223-9 (42 U.S.C. 6962(i)(2)(C)). (Not applicable to the acquisition of commercially available
off-the-shelf items.)___ (38) 52.223-11, Ozone-Depleting Substances and High Global Warming Potential Hydrofluorocarbons (June, 2016) (E.O. 13693).
___ (39) 52.223-12, Maintenance, Service, Repair, or Disposal of Refrigeration Equipment and Air Conditioners (June, 2016) (E.O.
13693).
___ (40)(i) 52.223-13, Acquisition of EPEAT[supreg]-Registered Imaging Equipment (Jun 2014) (E.O.s 13423 and 13514).
___ (ii) Alternate I (Oct 2015) of 52.223-13.
___ (41)(i) 52.223-14, Acquisition of EPEAT[supreg]-Registered Televisions (Jun 2014) (E.O.s 13423 and 13514).
___ (ii) Alternate I (Jun 2014) of 52.223-14.
___ (42) 52.223-15, Energy Efficiency in Energy-Consuming Products (May 2020) (42 U.S.C. 8259b).
___ (43)(i) 52.223-16, Acquisition of EPEAT[supreg]-Registered Personal Computer Products (Oct 2015) (E.O.s 13423 and 13514).
___ (ii) Alternate I (Jun 2014) of 52.223-16.
___ (44) 52.223-18, Encouraging Contractor Policies to Ban Text Messaging While Driving (Jun 2020) (E.O. 13513).
___ (45) 52.223-20, Aerosols (June, 2016) (E.O. 13693).
___ (46) 52.223-21, Foams (June, 2016) (E.O. 13693).
___ (47)(i) 52.224-3, Privacy Training (JAN 2017) (5 U.S.C. 552a).
___ (ii) Alternate I (JAN 2017) of 52.224-3.

Reference No. of Document Being Continued

CONTINUATION SHEET

Page 48 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
___ (48) 52.225-1, Buy American--Supplies (MAY 2014) (41 U.S.C. chapter 83).
___ (49)(i) 52.225-3, Buy American--Free Trade Agreements--Israeli Trade Act (MAY 2014) (41 U.S.C. chapter 83, 19 U.S.C. 3301 note,
19 U.S.C. 2112 note, 19 U.S.C. 3805 note, 19 U.S.C. 4001 note, Pub. L. 103-182, 108-77, 108-78, 108-286, 108-302, 109-53, 109-169, 109283, 110-138, 112-41, 112-42, and 112-43.
___ (ii) Alternate I (MAY 2014) of 52.225-3.
___ (iii) Alternate II (MAY 2014) of 52.225-3.
___ (iv) Alternate III (MAY 2014) of 52.225-3.
___ (50) 52.225-5, Trade Agreements (Oct 2019) (19 U.S.C. 2501, et seq., 19 U.S.C. 3301 note).
___ (51) 52.225-13, Restrictions on Certain Foreign Purchases (Jun 2008) (E.o.s, proclamations, and statutes administered by the
Office of Foreign Assets Control of the Department of the Treasury).
___ (52) 52.225-26, Contractors Performing Private Security Functions Outside the United States (Jul 2013) (Section 862, as amended,of the National Defense Authorization Act for Fiscal Year 2008; 10 U.S.C. 2302 Note).
___ (53) 52.226-4, Notice of Disaster or Emergency Area Set-Aside (Nov 2007) (42 U.S.C. 5150).
___ (54) 52.226-5, Restrictions on Subcontracting Outside Disaster or Emergency Area (Nov 2007)(42 U.S.C. 5150).
___ (55) 52.229-12, Tax on Certain Foreign Procurements (JUN 2020).
___ (56) 52.232-29, Terms for Financing of Purchases of Commercial Items (Feb 2002)(41 U.S.C. 4505, 10 U.S.C. 2307(f)).
___ (57) 52.232-30, Installment Payments for Commercial Items (Jan 2017)(41 U.S.C. 4505, 10 U.S.C. 2307(f)).
_X__ (58) 52.232-33, Payment by Electronic Funds Transfer -- System for Award Management (Oct 2018)(31 U.S.C. 3332).
___ (59) 52.232-34, Payment by Electronic Funds Transfer -- Other Than System for Award Management (Jul 2013)(31 U.S.C. 3332).
___ (60) 52.232-36, Payment by Third Party (MAY 2014) (31 U.S.C. 3332).
___ (61) 52.239-1, Privacy or Security Safeguards (Aug 1996)(5 U.S.C. 552a).
_X__ (62) 52.242-5, Payments to Small Business Subcontractors (Jan 2017)(15 U.S.C. 637(d)(13)).
___ (63)(i) 52.247-64, Preference for Privately Owned U.S.-Flag Commercial Vessels (Feb 2006)(46 U.S.C. Appx 1241(b) and 10 U.S.C.
2631).
___ (ii) Alternate I (Apr 2003) of 52.247-64.
___(iii) Alternate II (Feb 2006) of 52.247-64.
(c) The Contractor shall comply with the FAR clauses in this paragraph (c), applicable to commercial services, that the Contracting
Officer has indicated as being incorporated in this contract by reference to implement provisions of law or executive orders applicableto acquisitions of commercial items:___ (1) 52.222-41, Service Contract Labor Standards (Aug 2018) (41 U.S.C. chapter 67).
___ (2) 52.222-42, Statement of Equivalent Rates for Federal Hires (MAY 2014) (29 U.S.C. 206 and 41 U.S.C. chapter 67).
___ (3) 52.222-43, Fair Labor Standards Act and Service Contract Labor Standards--Price Adjustment (Multiple Year and Option
Contracts) (MAY 2014) (29 U.S.C. 206 and 41 U.S.C. chapter 67).
___ (4) 52.222-44, Fair Labor Standards Act and Service Contract Labor Standards--Price Adjustment (MAY 2014) (29 U.S.C 206 and 41
U.S.C. chapter 67).
___ (5) 52.222-51, Exemption from Application of the Service Contract Labor Standards to Contracts for Maintenance, Calibration, orRepair of Certain Equipment--Requirements (MAY 2014) (41 U.S.C. chapter 67).
___ (6) 52.222-53, Exemption from Application of the Service Contract Labor Standards to Contracts for Certain Services--

CONTINUATION SHEET

Reference No. of Document Being Continued

Page 49 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
Requirements (MAY 2014) (41 U.S.C. chapter 67).
___ (7) 52.222-55, Minimum Wages Under Executive Order 13658 (Nov 2020) (Executive Order 13658).
___ (8) 52.222-62, Paid Sick Leave Under Executive Order 13706 (Jan 2017) (E.O. 13706).
___ (9) 52.226-6, Promoting Excess Food Donation to Nonprofit Organizations (Jun 2020) (42 U.S.C. 1792).
(d) Comptroller General Examination of Record. The Contractor shall comply with the provisions of this paragraph (d) if this contract
was awarded using other than sealed bid, is in excess of the simplified acquisition threshold, as defined in FAR 2.101, on the date ofaward of this contract, and does not contain the clause at 52.215-2, Audit and Records -- Negotiation.
(1) The Comptroller General of the United States, or an authorized representative of the Comptroller General, shall have access to andright to examine any of the Contractors directly pertinent records involving transactions related to this contract.
(2) The Contractor shall make available at its offices at all reasonable times the records, materials, and other evidence for
examination, audit, or reproduction, until 3 years after final payment under this contract or for any shorter period specified in FAR
Subpart 4.7, Contractor Records Retention, of the other clauses of this contract. If this contract is completely or partiallyterminated, the records relating to the work terminated shall be made available for 3 years after any resulting final termination
settlement. Records relating to appeals under the disputes clause or to litigation or the settlement of claims arising under or relating
to this contract shall be made available until such appeals, litigation, or claims are finally resolved.
(3) As used in this clause, records include books, documents, accounting procedures and practices, and other data, regardless of typeand regardless of form. This does not require the Contractor to create or maintain any record that the Contractor does not maintain in
the ordinary course of business or pursuant to a provision of law.
(e)(1) Notwithstanding the requirements of the clauses in paragraphs (a), (b), (c) and (d) of this clause, the Contractor is not
required to flow down any FAR clause, other than those in this paragraph (e)(1) in a subcontract for commercial items. Unless otherwise
indicated below, the extent of the flow down shall be as required by the clause-(i) 52.203-13, Contractor Code of Business Ethics and Conduct (Jun 2020) (41 U.S.C. 3509).
(ii) 52.203-19, Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements (JAN 2017) (section 743 of
Division E, Title VII, of the Consolidated and Further Continuing Appropriations Act, 2015 (Pub. L. 113-235) and its successor
provisions in subsequent appropriations acts (and as extended in continuing resolutions)).
(iii) 52.204-23, Prohibition on Contracting for Hardware, Software, and Services Developed or Provided by Kaspersky Lab and Other
Covered Entities (Jul 2018) (Section 1634 of Pub. L. 115-91).
(iv) 52.204-25, Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment. (AUG 2020)(Section 889(a)(1)(A) of Pub. L. 115-232).
(v) 52.219-8, Utilization of Small Business Concerns (Oct 2018) (15 U.S.C. 637(d)(2) and (3)), in all subcontracts that offer
further subcontracting opportunities. If the subcontract (except subcontracts to small business concerns) exceeds the applicable
threshold specified in FAR 19.702(a) on the date of subcontract award, the subcontractor must include 52.219-8 in lower tiersubcontracts that offer subcontracting opportunities.
(vi) 52.222-21, Prohibition of Segregated Facilities (Apr 2015).
(vii) 52.222-26, Equal Opportunity (Sep 2016) (E.O. 11246).
(viii) 52.222-35, Equal Opportunity for Veterans (Jun 2020)(38 U.S.C. 4212).
(ix) 52.222-36, Equal Opportunity for Workers with Disabilities (Jun 2020)(29 U.S.C. 793).
(x) 52.222-37, Employment Reports on Veterans (Jun 2020) (38 U.S.C. 4212).
(xi) 52.222-40, Notification of Employee Rights Under the National Labor Relations Act (DEC 2010) (E.O. 13496).
(xii) 52.222-41, Service Contract Labor Standards (Aug 2018) (41 U.S.C. chapter 67).
(xiii)(A) 52.222-50, Combating Trafficking in Persons (Oct 2020) (22 U.S.C. 7104(g)).
(B) Alternate I (Mar 2015) of 52.222-50 (22 U.S.C. 7104(g)).

CONTINUATION SHEET

Reference No. of Document Being Continued

Page 50 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
(xiv) 52.222-51, Exemption from Application of the Service Contract Labor Standards to Contracts for Maintenance, Calibration, orRepair of Certain Equipment--Requirements (MAY 2014) (41 U.S.C. chapter 67).
(xv) 52.222-53, Exemption from Application of the Service Contract Labor Standards to Contracts for Certain Services--Requirements(MAY 2014) (41 U.S.C. chapter 67).
(xvi) 52.222-54, Employment Eligibility Verification (Oct 2015).
(xvii) 52.222-55, Minimum Wages Under Executive Order 13658 (Nov 2020) (Executive Order 13658).
(xviii) 52.222-62 Paid Sick Leave Under Executive Order 13706 (Jan 2017) (E.O. 13706).
(xix)(A) 52.224-3, Privacy Training (JAN 2017) (5 U.S.C. 552a).
(B) Alternate I (JAN 2017) of 52.224-3.
(xx) 52.225-26, Contractors Performing Private Security Functions Outside the United States (Jul 2013) (Section 862, as amended, ofthe National Defense Authorization Act for Fiscal Year 2008; 10 U.S.C. 2302 Note).
(xxi) 52.226-6, Promoting Excess Food Donation to Nonprofit Organizations (Jun 2020) (42 U.S.C. 1792). Flow down required inaccordance with paragraph (e) of FAR clause 52.226-6.
(xxii) 52.247-64, Preference for Privately-Owned U.S. Flag Commercial Vessels (Feb 2006)(46 U.S.C. Appx 1241(b) and 10 U.S.C. 2631).
Flow down required in accordance with paragraph (d) of FAR clause 52.247-64.
(2) While not required, the Contractor may include in its subcontracts for commercial items a minimal number of additional clauses
necessary to satisfy its contractual obligations.
(End of Clause)21

52.217-7

OPTION FOR INCREASED QUANTITY--SEPARATELY PRICED LINE ITEM

MAR/1989

The Government may require the delivery of the numbered line item, identified in the Schedule as an option item, in the quantity and at
the price stated in the Schedule. (b) (4)(End of Clause)

CONTINUATION SHEET

Reference No. of Document Being Continued

Page 51 of 51

W15QKN-21-C-0012

PIIN/SIIN

MOD/AMDName of Offeror or Contractor: PFIZER INC.
LIST OF ATTACHMENTS

List of________________
AddendaExhibit A
Attachment 0001
Attachment 0002____________________________________________________________
Title
CONTRACT DATA REQUIREMENTS LISTSDISCLOSURE OF LOBBYING ACTIVITIESPFIZER, INC. SUBCONTRACTING PLAN_______________
Date
22-DEC-2020
01-MAR-2020

Numberof Pages____________
Transmitted By_______________
009
EMAIL
002
EMAIL
014
EMAIL

INSTRUCTIONS FOR COMPLETION OF SF-LLL, DISCLOSURE OF LOBBYING ACTIVITIESThis disclosure form shall be completed by the reporting entity, whether subawardee or prime Federal recipient, at the initiation or receipt of a covered Federal
action, or a material change to a previous filing, pursuant to title 31 U.S.C. section 1352. The filing of a form is required for each payment or agreement to makepayment to any lobbying entity for influencing or attempting to influence an officer or employeeof any agency, a Member of Congress, an officer or employee ofCongress, or an employeeof a Member of Congress in connection with a covered Federal action. Complete all items that apply for both the initial filing and materialchange report. Refer to the implementing guidance published by the Office of Management and Budget for additional information.

1. Identify the type of covered Federal action for which lobbying activity is and/or has been secured to influence the outcome of a covered Federal action.
2. Identify the status of the covered Federal action.
3. Identify the appropriate classification of this report. If this is a followup report caused by a material change to the information previously reported, enter
the year and quarter in which the change occurred. Enter the date of the last previously submitted report by this reporting entity for this covered Federal
action.
4. Enter the full name, address, city, State and zip code of the reporting entity. Include Congressional District, if known. Check the appropriateclassificationof the reporting entity that designates if it is, or expects to be, a prime or subaward recipient. Identify the tier of the subawardee,e.g., the first subawardeeof the prime is the 1st tier. Subawards include but are not limited to subcontracts, subgrants and contract awards under grants.
5. If the organization filing the report in item 4 checks "Subawardee," then enter the full name, address, city, State and zip code of the prime Federal
recipient. Include Congressional District, if known.
6. Enter the name of the Federal agency making the award or loan commitment. Include at least one organizationallevel below agency name, if known. For
example, Department of Transportation, United States Coast Guard.
7. Enter the Federal program name or description for the covered Federal action (item 1). If known, enter the full Catalog of Federal Domestic Assistance(CFDA) number for grants, cooperative agreements, loans, and loan commitments.
8. Enter the most appropriate Federal identifying number available for the Federal action identified in item 1 (e.g., Request for Proposal (RFP) number;
Invitation for Bid (IFB) number; grant announcement number; the contract, grant, or loan award number; the application/proposal control number
assigned by the Federal agency). Include prefixes, e.g., "RFP DE 90 001."
9. For a covered Federal action where there has been an award or loan commitment by the Federal agency, enter the Federal amount of the award/loancommitment for the prime entity identified in item 4 or 5.
10. (a) Enter the full name, address, city, State and zip code of the lobbying registrant under the Lobbying Disclosure Act of 1995 engaged by the reporting
entity identified in item 4 to influence the covered Federal action.
(b) Enter the full names of the individual(s) performing services, and include full address if different from 10 (a). Enter Last Name, First Name, andMiddle Initial (MI).
11. The certifying official shall sign and date the form, print his/her name, title, and telephone number.
According to the Paperwork Reduction Act, as amended, no persons are required to respond to a collection of information unless it displays a valid OMB Control
Number. The valid OMB control number for this information collection is OMB No. 0348 0046. Public reporting burden for this collection of information isestimated to average 10 minutes per response, including time for reviewing instructions, searching existing data sources, gathering and maintaining the dataneeded, and completing and reviewing the collection of information. Send comments regarding the burden estimate or any other aspect of this collection of
information, including suggestions for reducing this burden, to the Office of Management and Budget, Paperwork Reduction Project (0348 0046), Washington,
DC 20503.

BPA NO.

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT
2. AMENDMENT/MODIFICATION NUMBER

3. EFFECTIVE DATE

03-01-2020

P00310CODE

6. ISSUED BY

003B6B

Department of Veterans Affairs
OPAL / National Acquisition Center
Building 37
1st Avenue, One Block North of Cermak
Hines IL 60141

8. NAME AND ADDRESS OF CONTRACTOR

1. CONTRACT D CODE

PAGE

1

4. REQUISITION/PURCHASE REQ. NUMBER

OF

PAGES

14

5. PROJECT NUMBER (if applicable)

20-2136
7. ADM NISTERED BY

CODE(If other than Item 6)

003B6B

Department of Veterans Affairs
OPAL / National Acquisition Center
Building 37
1st Avenue, One Block North of Cermak
Hines IL 60141(Number, street, county, State and Z P Code)(X)

PFIZER INC.
PFIZER

9A. AMENDMENT OF SOLICITATION NUMBER

9B. DATED (SEE ITEM 11)

235 E 42ND ST

10A. MODIFICATION OF CONTRACT/ORDER NUMBERXNEW YORK NY 10017

V797D-40269

10B. DATED (SEE ITEM 13)
CODE

86491

11-01-2014

FACILITY CODE

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers
is extended,
is not extended.
Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:(a) By completing Items 8 and 15, and returning __________ copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of theoffer submitted; or (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOURACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY
RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letteror electronic communication, provided each letter or electronic communication makes reference to the solicitation and this amendment, and is received prior tothe opening hour and date specified.
12. ACCOUNT NG AND APPROPRIATION DATA

(If required)

13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS,
IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

CHECKONE A. THIS CHANGE ORDER IS ISSUED PURSUANT TO:(Specify authority) THE CHANGES SET FORTH N ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. N ITEM 10A.

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADM NISTRATIVE CHANGESSET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

(such as changes in paying office, appropriation date, etc.)

C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:X

D. OTHER (Specify type of modification and authority)

E. IMPORTANT:

Contractor

X is not,14. DESCR PTION OF AMENDMENT/MOD FICATION

52.219-9 Small Business Subcontracting Plan0is required to sign this document and return ___________
copies to the issuing office.

(Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

65IB Small Business Subcontracting Plan for 2020.
This unilateral modification is being issued to incorporate the approved Commercial and Company-Wide Small
Business Subcontracting Plan into FSS contract referenced in Block 10A. Although the effective date of thismodification is 03/01/2020, the effective period of the plan is from 01/01/2020 to 12/31/2020.
The plan consists of 13 pages and is attached hereto.

Except as provided herein, all terms and conditions of the document referenced in tem 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.
15A. NAME AND TITLE OF SIGNER(Type or print)

16A. NAME AND TITLE OF CONTRACT NG OFFICER(Type or print)(b) (6)

Contracting Officer

15B. CONTRACTOR/OFFEROR(Signature of person authorized to sign)
PREVIOUS EDITION NOT USABLE

15C. DATE SIGNED(b) (6)(b) (6)
acting Officer)
STANDARD FORM 30 (REV. 11/2016)
Prescribed by GSA - FAR (48 CFR) 53.243

Page 5

Page 9

Page 11

Page 12